Korean Journal of Microbiology (미생물학회지)

The Microbiological Society of Korea (한국미생물학회)
권호 표지

The Production and Characterization of a Monoclonal Antibody to Herpes simplex Virus Type 2

Herpes simplex 2형 바이러스에 대한 단클론항체 생산과 항원 분석

  • 최경은 (건국대학교 이과대학 생물학과) ;
  • 이형환 (건국대학교 이과대학 생물학과) ;
  • 조명환 (건국대학교 이과대학 생물학과)
  • Published : 1997.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Herpes simpex virus type 2 (HSV-2) infects the genital and oral mucosae of human and other animals. HSV-2 infection is a widespread health problem causing various clinical syndromes including oral, genital, and ocular lesions, viral encephalitis, and recurrent diseases. Hybridorna cell lines secreting a monoclonal antibody (mAb) against the HSV-2 were produced by fusing spleen cells of HSV-2-immunized mice with Sp2/0-AgI4 myeloma cells. One hybridoma cell line was established and its monoclonal C-2, IgM, recognized the antigens of 134, 86, and 43 kDa in western blot analysis. In SDS-P AGE analysis of HSV -2 antigens, 25 bands were separated between 3D kDa and 159 kDa. In indirect immunofluorescent assay, mAbs exhibited binding to the virus antigen expressed on Vero cell infected with HSV-2.

인간을 비롯하여 여러 동물의 생식기와 구강. 안구 점막에 수포성, 괴양성 병변을 일으키는 Herpes simplex 2형 바이러스(HSV-2)에 대한 단클론항체를 하이브리도마 기술을 이용해 생사하였다. 생산된 단클론항체 C-2는 western blotting에서 134, 86 그리고 43 kDa의 분자량을 갖는 항원을 인식하였다. C-2의 isotype은 IgM이었다. SDS-PAGE를 이용하여 HSV-2에 감염되어 원형의 다핵 거세포를 형성한 vero 세포주를 인식하였으며, 이는 HSV-2 항원이 숙주세포에서 발현되고 있음을 알 수 있다. 이 결과는 HSV-2 백신개발의 목표항원이 되는 항원검출과 HSV-2 감염 진단법 개발에 기초가 될 수 있을 것이다.

Keywords

References

  1. J. Virol. v.67 The UL10 gene of herpes simplex virus 1 encodes a novel glycoprotein, gM, which is present in the virion and the plasma membrane of infectes cells Baines, J. D.;B. Roizman
  2. N. Engl. J. Med. v.324 Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor Brown Z. A.;J. Benedetti;R. Ashley
  3. Rev. Infec. Dis. v.13 no.SUP.11 Development of a herpes simplx virus submit glycoprotein vacine for prophylactic and therapeutic use Burke, R. L.
  4. J. Infec. Dis. v.157 Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pig Burman, P. W.;P. E. Vogt;T. Gregory;L. A. Lasky;E. R. Kern
  5. J. Virol. v.64 Glycoprotein D of herpes simplex virus encodes a domain witch precludes penetration of cells expresing the glycoprotein by superingecting herpes simplex virus Campadelli-Fiume, G.;S. Qi;E. Avitabile;L. Foa-Tomasi;R. Braqudimarti;B. Roizman
  6. Sur. Ophthalmol. v.21 Herpes simplex eye Infections: Clinical manifestations. pathogenesis and management Chandler, R.;M. D. Dawson;T. Birgitta
  7. Ann. Intern. Med. v.98 Genital herpes simplex virus infections; clinical manifestations. course and complication Corey, L.;H. G. Adams;Z. A. Brown;K. K. Holms
  8. N. Engl. J. Med. v.314 Infections with herpes simplex viruses Corey, L.;P. G. Spear
  9. Med. Microbilo. Immunol. v.183 A vaccinia virus-herpes simplex virus glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunisuppression and protect against vaginal challenge in BALB/c Fleck, M.;J. Podlech;K. Weise;D. Falke
  10. J. Virol. v.10 Arrangement of heprpesvirus deoxyribonucleic acid in the core Furlong, D.;H. Swift;B. Roizman
  11. Virology v.126 Inhibition of glycosylation of herpes simplex virus glycoproteins: Immunogenicity and antigenicity of partially glycoslyated glycoproteins Glorioso, J.;M. S. Szezesiul;S. D. Marlin;M. Levine
  12. J. Virol. v.3 Proteins specified by Herpes simplex virus. Ⅵ. viral proteins in the plasma membrane Heine, J. W.;P. G. Spear;B. Roizman
  13. J. Virol. v.69 Immunization with recombinat Varicella-Zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pig Heineman, T. C.;B. L. Connelly;N. Bourne;L. R. Stanberry;J. Cohen
  14. J. Virol. v.12 Proteins specified by herpes simplex virus. XI. Identification and relative molar rates of synthrsis of structural and nonstructural herpes virus polypeptides in the infected cell Honess, R. W.;B. Roizman
  15. J. Virol. Proteins specified by Herpes simplex virus. XIII. Glycosylation of viral polypeptides Honess, R. W.;B. Roizman
  16. J. Infec. Dis. v.165 Herpes simplex virus infection as a risk factor for human immunodificiency virus infection in heterosexulsls Hook, E. W. III;R. O. Cannon;A. J. Nahmias(et al.)
  17. J. Virol. v.66 Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion Hutchinson, L.;K. Goldsmith;D. Snoddy;H. Ghosh;F. L. Graham;D. C. Jonson
  18. N. Engl. J. Med. v.321 A seropidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States Jonson, R. E.;A. J. Nahmias;L. S. Magder;F. K. Lee;C. A. Brooks;C. B. Snowden
  19. Treatment of genital herpes simplex virus ingections in guinea pigs Kern, E. R.;L. Glasgow;Rapp, F.(ed.)
  20. DNA sequence analysis of the type-common glycoprotein D genes of herpes simplex virus types 1 and 2 DNA v.3 Lasky, L. A.;D. J. Dowbenco
  21. Ann. Intern. Med. v.116 Risk factors for the sexual transmission of genital herpes Mertz, G. J.;J. Benedetti;R. Ashley;S. A. Selke;L. Corey
  22. The bloomsbury series in clinical science: Herpes simplex virus Mindel A
  23. J. Exp. Med. v.10 Electron microscopic observation on the development of herpes simplex virus Morgan, C.;H. M. Rose;M. Holden;E. P. Jones
  24. J. Infec. Dis. v.169 Immunotherapy of acute and recurrent herpes simples virus type 2 infection with and adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein Nakao, M.;M. Hazama;A. Mayumi-Aono;S. Hinuma;Y. Fujisawa
  25. J. Virol. v.32 Herpes simplex virus glycoproteins: participation in immune cytolysis and their correlation with previously identified glycopeptodes Norrild, B.;S. L. Shore;A. J. Nahmias
  26. Immun. v.28 Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infections cycle as determined by antibody dependent cellmediated cytotoxicity Norrild, B.;S. L. Shore;T. L. Cromeans;A. J. Nahmias
  27. Virology v.66 Polypeptides synthesized in herpes simplex virus type 2 infected HEp-2 cells Powell, K. L.;R. J. Courtney
  28. Comprehensive virology v.3 The replication of herpesvirues Roizman, B.;D. Furlong;Fraenkel-Conrat, H.(eds.);R. R. Wagner(eds.)
  29. Brain. Res. v.440 Mortality in an exprimental focal herped encephalitis relationship to seizure Schlitt, M.;A. P. Bucher;W. G. Stroop(et al.)
  30. Oral. Surg. Med. Pathol. v.32 Intraoral lesions of asults associated with herpes simplex virus Sheridan, P. J.;E. C. J. Hermann
  31. J. Gen. Virol. v.68 Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope Stannard, L. M.;A. O. Fuller;P. G. Spear
  32. Virology v.69 Proteins of Herpesvirus type2: 1. virion, nonvirion, and antigenic polypeptised in infected cell Strand, B. C.;L. Aurelian
  33. J. Infec. Dis. v.167 Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombimant glycoprotien D vaccine Straus, S. E.;B. Savares;M. Tigges;A. G. Freifeld;P. R. Krause;D. M. Margolis;J. L. Meier;D. P. Paar;S. F. Adair;D. Dina;C. Dekker;R. L. Burke
  34. Gene. v.23 DNA sequence of the herpes simplex virus type 2 glycoprotein D gene Wason, R. J.